AngioDynamics
Focus: AngioDynamics is a medical device company headquartered in Hong Kong with a broad portfolio spanning oncology, vascular, and interventional procedures. The company develops minimally invasive therapeutic systems across multiple clinical areas.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Open Jobs
2
Should You Work at AngioDynamics?
AI assessmentAngioDynamics presents a specialized device company opportunity with interesting oncology and interventional assets, but limited hiring velocity and opaque financials create uncertainty for career planners.
Why Work Here
- Diverse pipeline across high-value oncology indications (pancreatic cancer, prostate cancer, hepatocellular carcinoma) with Phase 3 programs actively advancing
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Irreversible Electroporation (NanoKnife System)
Prostate CancerMechanical Aspiration System (AlphaVac)
Acute Pulmonary EmbolismHelp build intelligence for AngioDynamics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.